Innovation in Clinical Trials

Innovation in Clinical Trials

"While contemplating the consequences of not innovating within clinical trial supply, the main factor highlighted was the loss of time". Experts discuss the consequences of no innovation in clinical supply, market culture, and current trends.


Please note: That all fields marked with an asterisk (*) are required.